Two-fold success for Medicine

Two successes for collaborative research at the University of Freiburg and Freiburg University Medical Center: the German Research Foundation (DFG) is providing the collaborative research center (CRC) ‘Nephrogenetics (NephGen)’ and the CRC ‘Development, function and potential of myeloid cells in the central nervous system’ (NeuroMac) in medicine with approximately 24 million euros in funding for the next four years.

Two collaborative research centers of the Freiburg University Medical Center receive funding.
Photo: Britt Schilling/The Medical Center – University of Freiburg

“I congratulate all my colleagues on their successful applications,” says rector Prof. Dr. Kerstin Krieglstein. “Once again this year the University of Freiburg has proven its special strength in interdisciplinary collaborative research with a total of six new or extended collaborative research centers, five in medicine and one in the humanities. We’ve attracted about 58 million euros for cutting-edge research for the coming four years with this funding format alone.”

The new CRC ‘Nephrogenetics (NephGen)’ is dedicated to searching for the mechanisms that cause kidney disease using genetic information. NephGen is receiving a total of 13.5 million euros for the coming four years. The project involves the Charité – Universitätsmedizin Berlin alongside the university and the Freiburg University Medical Center. Its coordinator is Prof. Dr. Anna Köttgen, director of the Institute of Genetic Epidemiology at Freiburg University Medical Center. Another four years funding has been awarded to the collaborative research center/ Transregio (CRC/TRR) 167 ‘Development, function and potential of myeloid cells in the central nervous system’ (NeuroMac), which studies the immune cells in the human brain. A total of 10.6 million euros will be available for this research over the next four years, 6.3 million of which will go to Freiburg. The research association includes the Max Planck Institute of Immunobiology and Epigenetics, Charité – Universitätsmedizin Berlin and the Weizmann Institute of Science in Rehovot, Israel, along with the university and Freiburg University Medical Center. Its coordinator is Prof. Dr. Marco Prinz, medical director of the Institute of Neuropathology at the Freiburg University Medical Center.

Nicolas Scherger

Further Informations

• Freiburg University Medical Center Press Release with detailed descriptions of the Medicine CRCs that are receiving funding (in German)
• DFG’s Press Release (in German)
• Press Rrelease of the University of Freiburg on the funding decisions of May 2020
• Website of the CRC/TRR ‘NeuroMac’